Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 March 2006:
Vol. 311. no. 5768, pp. 1721 - 1723
DOI: 10.1126/science.1125884
Prev | Table of Contents | Next

Perspectives

BIOMEDICINE:
Lowering LDL--Not Only How Low, But How Long?

Michael S. Brown and Joseph L. Goldstein

People with a mutation in a proteolytic enzyme are at a substantially lower risk for coronary heart disease because of their lifelong reduction of plasma low-density lipoprotein.

The authors are in the Department of Molecular Genetics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9046, USA. Email: mike.brown{at}utsouthwestern.edu, joe.goldstein{at}utsouthwestern.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Lack of Phosphatidylethanolamine N-Methyltransferase Alters Plasma VLDL Phospholipids and Attenuates Atherosclerosis in Mice.
Y. Zhao, B. Su, R. L. Jacobs, B. Kennedy, G. A. Francis, E. Waddington, J. T. Brosnan, J. E. Vance, and D. E. Vance (2009)
Arterioscler Thromb Vasc Biol 29, 1349-1355
   Abstract »    Full Text »    PDF »
The LDL Receptor.
J. L. Goldstein and M. S. Brown (2009)
Arterioscler Thromb Vasc Biol 29, 431-438
   Abstract »    Full Text »    PDF »
Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population.
E. S. Tai, X. L. Sim, T. H. Ong, T. Y. Wong, S. M. Saw, T. Aung, S. Kathiresan, M. Orho-Melander, J. M. Ordovas, J. T. Tan, et al. (2009)
J. Lipid Res. 50, 514-520
   Abstract »    Full Text »    PDF »
Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels.
G. Mayer, S. Poirier, and N. G. Seidah (2008)
J. Biol. Chem. 283, 31791-31801
   Abstract »    Full Text »    PDF »
Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia.
D. Steinberg, C. K. Glass, and J. L. Witztum (2008)
Circulation 118, 672-677
   Full Text »    PDF »
Errata. PCSK9 function and physiology.
A. S. Peterson, L. G. Fong, and S. G. Young (2008)
J. Lipid Res. 49, 1595-1599
   Abstract »    Full Text »    PDF »
PCSK9 function and physiology.
A. S. Peterson, L. G. Fong, and S. G. Young (2008)
J. Lipid Res. 49, 1152-1156
   Full Text »    PDF »
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events.
S. Kathiresan, O. Melander, D. Anevski, C. Guiducci, N. P. Burtt, C. Roos, J. N. Hirschhorn, G. Berglund, B. Hedblad, L. Groop, et al. (2008)
N. Engl. J. Med. 358, 1240-1249
   Abstract »    Full Text »    PDF »
State of the Art Reviews: The Oatmeal-Cholesterol Connection: 10 Years Later.
M. B. Andon and J. W. Anderson (2008)
American Journal of Lifestyle Medicine 2, 51-57
   Abstract »    PDF »
Promise of Low-Density Lipoprotein-Lowering Therapy for Primary and Secondary Prevention.
S. M. Grundy (2008)
Circulation 117, 569-573
   Full Text »    PDF »
The Proprotein Convertase PCSK9 Induces the Degradation of Low Density Lipoprotein Receptor (LDLR) and Its Closest Family Members VLDLR and ApoER2.
S. Poirier, G. Mayer, S. Benjannet, E. Bergeron, J. Marcinkiewicz, N. Nassoury, H. Mayer, J. Nimpf, A. Prat, and N. G. Seidah (2008)
J. Biol. Chem. 283, 2363-2372
   Abstract »    Full Text »    PDF »
The Liver X Receptor and Atherosclerosis.
J. Scott (2007)
N. Engl. J. Med. 357, 2195-2197
   Full Text »    PDF »
Vascular Adhesion Molecules in Atherosclerosis.
E. Galkina and K. Ley (2007)
Arterioscler Thromb Vasc Biol 27, 2292-2301
   Abstract »    Full Text »    PDF »
Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis.
C.-L. Chen, I-H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang (2007)
J. Cell Sci. 120, 3509-3521
   Abstract »    Full Text »    PDF »
Forgotten but Not Gone: The Rediscovery of Fatty Heart, the Most Common Unrecognized Disease in America.
L. S. Szczepaniak, R. G. Victor, L. Orci, and R. H. Unger (2007)
Circ. Res. 101, 759-767
   Abstract »    Full Text »    PDF »
Update on Dyslipidemia.
A. Garg and V. Simha (2007)
J. Clin. Endocrinol. Metab. 92, 1581-1589
   Abstract »    Full Text »    PDF »
Genetic susceptibility to myocardial infarction and coronary artery disease.
E. J. Topol, J. Smith, E. F. Plow, and Q. K. Wang (2006)
Hum. Mol. Genet. 15, R117-R123
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)